• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙调蛋白拮抗剂(三氟拉嗪和W-7)对低温缺血大鼠心脏的保护作用。

Protective effects of calmodulin antagonists (trifluoperazine and W-7) on hypothermic ischemic rat hearts.

作者信息

Sugawara E, Nakayama Y, Senoo Y, Teramoto S

机构信息

Second Department of Surgery, Okayama University Medical School, Japan.

出版信息

Acta Med Okayama. 1991 Jun;45(3):129-34. doi: 10.18926/AMO/32210.

DOI:10.18926/AMO/32210
PMID:1891973
Abstract

The cardioprotective effect of calmodulin antagonists, trifluoperazine (TFP) and N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide (W-7) was examined on the isolated rat heart exposed to hypothermic and ischemic conditions by measuring distribution of lysosomal enzymes in myocardial cells, and leakage of creatine kinase (CK) during reperfusion and postischemic recovery in myocardial systolic function. Experimental hearts were infused with 20 degrees C Krebs-Henseleit bicarbonate buffer (KHB) or KHB containing TFP or W-7 for 2min every 30min during hypothermic ischemia. After ischemia for 120min at 20 degrees C, rat hearts were reperfused at 37 degrees C for 30min. TFP and W-7 improved functional recovery and prevented CK release. In TFP treated hearts, leakage of lysosomal enzymes was reduced significantly, whereas stabilization of lysosomes by W-7 did not occur. These results suggest that calcium-calmodulin dependent enzymes may play an important role in the development of cellular damage of the myocardium during hypothermic ischemia, although levels of leakage of lysosomal enzymes may be unreliable predictors of functional recovery after hypothermic ischemia.

摘要

通过测量心肌细胞中溶酶体酶的分布以及再灌注期间肌酸激酶(CK)的泄漏和低温缺血后心肌收缩功能的恢复情况,研究了钙调蛋白拮抗剂三氟拉嗪(TFP)和N-(6-氨基己基)-5-氯-1-萘磺酰胺(W-7)对暴露于低温和缺血条件下的离体大鼠心脏的心脏保护作用。在低温缺血期间,每隔30分钟向实验心脏灌注20℃的 Krebs-Henseleit 碳酸氢盐缓冲液(KHB)或含TFP或W-7的KHB 2分钟。在20℃缺血120分钟后,将大鼠心脏在37℃再灌注30分钟。TFP和W-7改善了功能恢复并防止了CK释放。在TFP处理的心脏中,溶酶体酶的泄漏显著减少,而W-7对溶酶体的稳定作用未出现。这些结果表明,钙-钙调蛋白依赖性酶可能在低温缺血期间心肌细胞损伤的发生中起重要作用,尽管溶酶体酶的泄漏水平可能不是低温缺血后功能恢复的可靠预测指标。

相似文献

1
Protective effects of calmodulin antagonists (trifluoperazine and W-7) on hypothermic ischemic rat hearts.钙调蛋白拮抗剂(三氟拉嗪和W-7)对低温缺血大鼠心脏的保护作用。
Acta Med Okayama. 1991 Jun;45(3):129-34. doi: 10.18926/AMO/32210.
2
Calmodulin antagonist reduces release of malondialdehyde from isolated ischemic/reperfused rat heart.钙调蛋白拮抗剂可减少离体缺血/再灌注大鼠心脏中丙二醛的释放。
Acta Physiol Pol. 1988 Sep-Dec;39(5-6):442-9.
3
Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat hearts.
J Cardiovasc Pharmacol. 1992 Aug;20(2):251-60. doi: 10.1097/00005344-199208000-00010.
4
Antagonists of calmodulin delay injury development in the severely ischemic perfused working rat heart.钙调蛋白拮抗剂可延缓严重缺血灌注的工作大鼠心脏损伤的发展。
Acta Physiol Pol. 1988 Jul-Aug;39(4):225-43.
5
Transient hypothermic reperfusion and postischemic recovery in isolated rat heart.离体大鼠心脏的短暂低温再灌注及缺血后恢复
Am J Physiol. 1990 Sep;259(3 Pt 2):H879-88. doi: 10.1152/ajpheart.1990.259.3.H879.
6
Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization.急性冠状动脉闭塞和冠状动脉血运重建后,钙调蛋白拮抗剂三氟拉嗪对心肌功能的改善作用。
J Thorac Cardiovasc Surg. 1989 Feb;97(2):267-74.
7
Anti-ischemic and membrane stabilizing activity of calmodulin inhibitors.
Basic Res Cardiol. 1989 Nov-Dec;84(6):631-45. doi: 10.1007/BF01906948.
8
Calmodulin antagonists stimulate renin release from isolated rat glomeruli.钙调蛋白拮抗剂可刺激从分离的大鼠肾小球释放肾素。
Endocrinology. 1983 May;112(5):1857-9. doi: 10.1210/endo-112-5-1857.
9
Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).已知可抑制钙调蛋白的药物(三氟拉嗪、W7和苄普地尔)的抗心律失常和电生理作用比较
Br J Pharmacol. 1986 Nov;89(3):603-12. doi: 10.1111/j.1476-5381.1986.tb11162.x.
10
Possible role of calmodulin in the control of lysosomal enzyme release from human polymorphonuclear leukocytes.
J Pharmacol Exp Ther. 1984 Dec;231(3):678-84.